Skip to NavigationSkip to content

Vectura’s COO set to step down

Published on: 08/03/17

Vectura’s Chief Operating Officer, Trevor Phillips, will step down from the board on 25 May before leaving the company on 31 May. According to Vectura, Phillips was a key figure in the acquisition of Activaero and its merger with Skyepharma in 2016. During the latter, he has also played a role in the integration between the companies.

Prior to working with Vectura, Phillips performed the role of COO and CEO of Critical Therapeutics – a company that was bought out by Cornerstone BioPharma in 2008, before its eventual takeover by Chiesi Farmaceutici. He had a role at GSK as CRM before this.

James Ward-Lilley, Chief Executive Officer, commented: "I would like to extend my personal thanks to Trevor for the support he has given me and for the highly professional way in which he has carried out his role in the business. Trevor has been with Vectura since 2010 and in that time he has been a significant driver of the transition of the Group into the business it is today. Having managed the initial integration of Skyepharma and Vectura, Trevor and I agreed that the AGM would be an appropriate time for him to transition out of the Company. The Board and I would like to thank Trevor for his contribution throughout his tenure, and we wish him well in his future endeavours."

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches